Growth differentiation factor 15 (GDF15) is a stress-responsive protein that rises in many chronic diseases. This commentary reviews six observational studies and a recent mechanistic report in inflammatory bowel disease (IBD). Most studies found higher circulating GDF15 in Crohn's disease and ulcerative colitis than in controls, and levels tracked inflammatory markers like IL-6 and CRP. In lab models using colonic organoids and T84 cells, GDF15 reduced the tight-junction proteins ZO-1 and claudin 1 and increased gut permeability. Yet animal work suggests GDF15 can also protect the mucosa. The authors conclude GDF15 is a double-edged mediator. Small cohorts, mostly patients in remission, and a lack of genetic validation mean it is too early to use GDF15 as a clinical biomarker or drug target.